Cel-Sci Corporation

Last updated September 27, 2026

Organization details

Legal name
Cel-Sci Corporation
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation
Colorado
Headquarters city
Vienna
Headquarters state / province
Virginia
Headquarters country
United States
Fiscal year end
September
Ticker symbol
CVM
Primary stock exchange
NYSE American

Identifiers

SEC CIK
0000725363
EIN
84-0916344
Wikidata ID
Q30282585

Board of directors

Chief executives

Geert R. Kersten · Chief Executive Officer
Dates unknown

Director election results

Annual meeting of August 14, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

1 of this board's directors also sit on 1 other board. 1 is in the same sector.

Network of Cel-Sci Corporation's board connections TherapeuticsMD Inc. TherapeuticsMD Inc. Gail K. Naughton Gail K. Naughton Cel-Sci Corporation
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$866,999
5 purchases by 1 insider
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Sep 30, 2026 Geert R. Kersten Director, Officer (Chief Executive Officer) Grant or award +2,621 $2.06 $5,399
Sep 30, 2026 PRICHEP PATRICIA B Officer (Chief Financial Officer) Grant or award +2,082 $2.06 $4,289
Sep 30, 2026 TALOR EYAL Officer (Chief Scientific Officer) Grant or award +1,165 $2.06 $2,400
Aug 25, 2026 Geert R. Kersten Director, Officer (Chief Executive Officer) Open-market purchase +100,000 $1.38 $138,000
Jun 30, 2026 Geert R. Kersten Director, Officer (Chief Executive Officer) Grant or award +5,192 $1.04 $5,400
Jun 30, 2026 PRICHEP PATRICIA B Officer (Chief Financial Officer) Grant or award +4,125 $1.04 $4,290
Jun 30, 2026 TALOR EYAL Officer (Chief Scientific Officer) Grant or award +2,307 $1.04 $2,399
May 14, 2026 Geert R. Kersten Director, Officer (Chief Executive Officer) Open-market purchase +300,000 $1.20 $360,000
May 13, 2026 Geert R. Kersten Director, Officer (Chief Executive Officer) Open-market purchase +100,000 $1.19 $119,000
Mar 31, 2026 TALOR EYAL Officer (Chief Scientific Officer) Grant or award +747 $3.21 $2,398
Mar 31, 2026 PRICHEP PATRICIA B Officer (Chief Financial Officer) Grant or award +1,336 $3.21 $4,289
Mar 31, 2026 Geert R. Kersten Director, Officer (Chief Executive Officer) Grant or award +1,682 $3.21 $5,399
Jan 22, 2026 Geert R. Kersten Director, Officer (Chief Executive Officer) Open-market purchase +38,023 $5.26 $200,001
Dec 31, 2025 TALOR EYAL Officer (Chief Scientific Officer) Grant or award +456 $5.26 $2,399
Dec 31, 2025 PRICHEP PATRICIA B Officer (Chief Financial Officer) Grant or award +815 $5.26 $4,287

Organizations in the same sector, closest in location and size first.

Questions about Cel-Sci Corporation

Who is the CEO of Cel-Sci Corporation?

Geert R. Kersten is Cel-Sci Corporation's Chief Executive Officer.

How many directors are on Cel-Sci Corporation's board?

Cel-Sci Corporation's board has 6 directors: Bruno Jean-Marie Baillavoine, Gail K. Naughton, Geert R. Kersten, Mario Gobbo, Peter R. Young and Robert Eugene Watson.

Are Cel-Sci Corporation insiders buying or selling shares?

Over the last 12 months, Cel-Sci Corporation insiders bought $866,999 of shares in 5 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="cel-sci-corporation"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.